The International Criteria for Behçet's Disease (ICBD) is a clinical scoring system used to diagnose Behçet's Disease, a rare and chronic multisystem inflammatory disorder. This calculator is applicable to patients presenting with symptoms suggestive of Behçet's Disease, such as recurrent oral and genital ulcers, eye inflammation, skin lesions, and other systemic manifestations.
The ICBD is clinically useful in standardizing the diagnosis of Behçet's Disease across different populations and clinical settings. It helps clinicians to make a more accurate diagnosis, guide treatment decisions, and predict disease course and prognosis.
The ICBD includes oral aphthosis, genital aphthosis, ocular lesions, skin lesions, and a positive pathergy test as diagnostic criteria. Each of these criteria is scored, and a certain score threshold must be met for a diagnosis of Behçet's Disease.
There are no specific exclusion criteria for the use of the ICBD. However, it should be noted that this scoring system is not intended to replace clinical judgment. Other differential diagnoses should be considered and ruled out before confirming a diagnosis of Behçet's Disease based on the ICBD score.
Reference
International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47.
Open reference URL